Soumitra Roy, an Indian Origin, Takes an Important Role in Managing Covid Vaccine and Antiviral Pill Supply Chain Globally
Dr. Juni Banerjee Phd, Neucrad Health, January 13,2022 Soumitra Roy, one of the covid vaccine supply chain lead for one...
COVID-19 Vaccine Development
Novavax vaccine (NVX-CoV2373): Promising Phase-III Human clinical-trial results against Covid-19
Dr. Juni Banerjee, PhD; Neucrad Health Desk, February 20, 2021 Maryland-based NovaVax Biopharma recently developed a protein-based novel coronavirus vaccine. The vaccine...
Sputnik V vaccine: science and clinical development
Dr. Juni Banerjee. Neucrad Health Desk, February 9, 2021 The Phase-III trial of Russia's Sputnik V vaccine revealed around 92%...
Covaxin: Why the controversy?
Dr. Shuvomoy Banerjee, PhD; Neucrad Health Desk 15th Jan, 2021 https://youtu.be/TpJCoaJaTN0 Recently, many leading companies from different countries of the...
The 90% effective Pfizer-BioNTech Covid-19 Vaccine! Phase III interim finding!!
Shuvomoy Banerjee, PhD; Neucrad Health Desk; November 17,2020 On one hand, SARS-Cov-2 is showing its havoc wrecking on humans and...
Covaxin and ZyCoV-D: Recent Update of Covid-19 Vaccine Candidates in India
Dr. Shuvomoy Banerjee, PhD.; from Neucrad Health desk, August 20,2020 More than 2.6 million people of India are currently infected...
COVID-19 VACCINE Candidates in India – Most Recent Update
Dr. Prangya P.Tripathy, PhD, Neucrad Health Desk, August 5, 2020 India has recorded single day increase of 52,972 in Covid-19 cases, and total...
Oxford University-AstraZeneca Covid-19 vaccine’s Human Trial Report is a Ray of Hope
Dr. Shuvomoy Banerjee, PhD; Neucrad Health Desk, July 22, 2020 Covid-19 killing more than six lakh people worldwide has made...
